EVO
Evotec SECNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
EVO vs peer average
52/100
EVO vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CRL is the first available peer comparator.
Charles River offers a useful read-through on outsourced discovery and early-development demand. Differences in scale, portfolio composition and ongoing business changes make it an imperfect direct peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EVO
Evotec SE
CRL
Charles River Laboratories International
Grade
C
D
Momentum
98
98
Value
41
58
Sentiment
56
32
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs CRL
EVO / CRL
Grade Position
In line
EVO vs. peer average (C vs. C)
52/100
Momentum
98
EVOValue
41
CRLSentiment
56
EVORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EVO
CRL is the first peer returned for this comparison set.